Panoramic Auto Fluorescence – Page 56 of 66
Case 8: Optomap® plus with Resmax™ FAF OD Note that the FAF images accentuate the abnormalities, especially the arcuate peri-foveal hypo AF zone which signifies death of RPE cells.
Case 8: Optomap® plus with Resmax™ FAF OD Note that the FAF images accentuate the abnormalities, especially the arcuate peri-foveal hypo AF zone which signifies death of RPE cells.
35 yo HM with a history of dots and spots in his fundus over the past decade. BCVA has remained 20/20 OU throughout this period. The appearance of the fundus is rather typical of Stargardt Macular Degeneration with Fundus Flavimaculatus. Note that the spots are not round as the vast majority of drusen
Case 7: Optomap® plus with Resmax™ FAF OD and OS Although the visual acuity is the same in each eye, the appearance of the central retina is dramatically different. This is a case of similar peripheral abnormalities but of different macula involvement. Does peripheral drusen and pigmentary changes increase the risk of macula
Case 7: Optomap® plus with Resmax™ FAF OS The preserved central vision in the left eye is due to the skill of the retinal surgeon combined with a little bit of good fortune. The CNVM has not recurred as well.
Case 7: Optomap® FAF OS The AF image demonstrates hypo AF in the treated lesion, confirming the destruction of the RPE. Peripheral findings are similar to those in the right eye.
Case 7: Optomap® Color Fundus Image OS In the left eye which was treated years earlier with laser, the retina, RPE and some of the choroid has been destroyed. The CNV membrane was successfully eliminated and the fovea was spared. See RR #32 for microperimety and SD OCT findings confirming this.
Case 7: Optomap® plus with Resmax FAF OD The dark spots below the disc are in different positions in each image and represent remnants of a PVD.
Case 7: Optomap® FAF OD The PAF image in the right eye has some correspondence with the color image.
Case 7: Optomap® Color Fundus Image OD An 89 yo WF presented for f/u for choroidal neovascularization in the OS which was treated with laser 6 years previously. The BCVA remains 20/30 in each eye. Although the macula has no drusen or pigmentary changes, the temporal retina displays drusen and the nasal retina reveals
Case 6: Optomap® plus with Resmax OS Note that the hypo AF lesions nasally do not correspond to the drusen and hence the AF images are yielding additional information. RR #27 * Courtesy of the Reykjavik Eye Study